USPTO serial 97705184
PST
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- TATE-NAGHI,JACQUELINE P
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leesa N. Weiss
Leesa N. Weiss Edell, Shapiro & Finnan, LLC9801 Washingtonian Blvd., Suite 750Gaithersburg, MD 20878United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising diagnostic reagents for testing bacteria sensitivity, except for medical or veterinary use; human, animal, plant and microorganism biological preparations for use in industry and science, namely, for use in drug development; Biological preparations for use in industry and science, namely, for treating bacterial contamination in the fields of farming and food preparation; Biological preparations for use in industry and science, namely, for treating bacterial contamination in the industrial and food preparation fields | ACTIVE | — |
| 005 | human, animal, plant and microorganism biological preparations for disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the field of medicine; diagnostic kits comprising medical diagnostic reagents for testing bacteria sensitivity | ACTIVE | — |
| 042 | new product research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and pharmaceuticals; medical laboratory services and scientific laboratory services in the nature of clinical and medical laboratory services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom biochemical assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; new product research and development of vaccines and therapeutics; providing temporary use of online non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; medical research, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; laboratory research services in the field of microbiological laboratory testing of bacteria for research purposes and technical consultation relating thereto; scientific and medical research, in particular, design and development of diagnostic assays; medical laboratory services in the nature of testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; medical laboratory services in the nature of microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto | ACTIVE | — |
| 044 | medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes, namely, providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; medical consulting services in the field of medical diagnostic and prognostic testing; medical services in the nature of medical analysis services for diagnostic and prognostic testing and treatment purposes; medical analysis services relating to the diagnosis and treatment of a person; medical testing and medical diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Adaptive Phage Therapeutics, Inc.
- Other trademarks owned by Adaptive Phage Therapeutics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PST
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 19, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 19, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 6, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 5, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 5, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 2, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 25, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 3, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 3, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 16, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 15, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 15, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 15, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 6, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 6, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 6, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 13, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 18, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 18, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 4, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 4, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 4, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 4, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 4, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 14, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2022 | NWAP | NEW APPLICATION ENTERED | — |